Involvement of Rho-kinase in experimental vascular endothelial dysfunction

Molecular and Cellular Biochemistry

Volumn 283, Issue 1-2, 2006, Pages 191-199

  Shah, Dhvanit I ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Diabetes mellitus; Fasudil; Hyperhomocysteinemia; Rho kinase; Vascular endothelial dysfunction

Indexed keywords

ACETYLCHOLINE; ATORVASTATIN; FASUDIL; GLUCOSE; HOMOCYSTEINE; METHIONINE; NITRATE; NITRITE; RHO KINASE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PYRROLE DERIVATIVE; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRON MICROSCOPY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING; ANIMAL; BLOOD; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; VASODILATATION;

ANIMALIA;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETYLCHOLINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AORTA, THORACIC; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERHOMOCYSTEINEMIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NITRATES; NITRITES; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASODILATION;

EID: 33645774175     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-2679-6     Document Type: Article

References (36)

1. Luscher TF, Vanhoutte PM: Endothelium dependent vascular response in normotensive and hypertensive Dahl rats. Hypertension 9: 157-163, 1987
2. Li H, Forstermann U: Nitric oxide in the pathogennesis of vascular disease. J Pathol 190: 244-262, 2000
3. De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000
4. Bonetti PO, Lerman A, Lerman A: Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175, 2003
5. Lentz SR, Rodionov RN, Dayal S: Hyperhomocysteinemia, endothelial dysfunction and cardiovascular risk: The potential role of ADMA. Atheroscler Suppl 4: 61-65, 2003
6. Somlyo AP, Somlyo AV: Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000
7. Hernandez-Perera O, Perez-Sala D, Soria E, Lamas S: Involvement of Rho GTPases in transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells. Circ Res 87: 616-622, 2000
8. Laufs U, Liao JK: Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271, 1998
9. Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z: Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22: 8467-8477, 2002
10. Shiotani S, Shimada M, Suehiro T, Soejima Y, Yosizumi T, Shimokawa H, Maehara Y: Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats. Transplantation 78: 375-382, 2004
11. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A: Long term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: Effect on endothelial NAD(P)H oxidase system. Circ Res 93: 767-775, 2003
12. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takashi S, Kaibuchi K, Takeshita A: Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery in a porcine model with interleukin 1-B. Circulation 101: 1319-1323, 2000
13. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis RL, Mills TM, Helstrom WJG, Kadowitz PJ: RhoA/Rho-kinae suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proct Nat Acad Sci 101: 9121-9126, 2004
14. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshita A: Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94: 385-393, 2004
15. Pieper GM, Langenstroer P, Siebeneich W: Diabetic induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals. Cardiovasc Res 37: 145-156, 1997
16. Pieper GM, Siebeneich W: Oral administration of the anioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 32: 101-105, 1998
17. 2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 20: 1203-1208, 2000
18. Dimitrova KR, DeGroot KW, Pacquing AM, Suyderhoud JP, Pirovic EA, Munro TJ, Wieneke JA, Myers AK, Kim YD: Estradiol prevents homocysteine-induced endothelial injury in male rats. Cardiovasc Res 53: 589-596, 2002
19. Mitra S, Singh M: Possible mechanism of captopril induced endothelium-dependet relaxation in isolated rabbit aorta. Mol Cell Biochem 183: 63-67, 1998
20. Ignarro LJ, Bryns RE, Buga GM, Wood KS, Chaudhari G: Pharmacological evidence that endothelium-derived relaxing factor is NO: Use of pyrogallol and superoxide dismutase to study endothelium dependent and NO-elicited vascular smooth muscle relaxation. J Pharmacol Exp Therap 244: 181-188, 1988
21. Schiller NK, Timothy AM, Chen IL, Rice RC, Akers DL, Kadowitz PJ, McNamaran DB: Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. Am J Physiol 277: 240-248, 1999
22. David GFX, Herbert J, Wright CDS: The ultrastructure of the pineal ganglion in the ferret. J Anat 115: 79-97, 1973
23. Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS: Spectophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306: 79-82, 2002
24. Ma FA, Liu LY, Xiong XM: Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacol Sin 24: 1027-1032, 2003
25. Wolfrum, S, Jensen KS, Liao JK: Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 23: 729-736, 2003
26. Zhou MS, Jaimes EA, Raij L: Atorvastatin prevents end-organ injury in salt-sensitive hypertension. Hypertension 44: 186-190, 2004
27. Kohn AD, Summer SA, Birnbaum MJ, Roth RA: Expression of constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocystes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996
28. Calera MR, Martinez C, Liu H, Jack AKE, Birnbaum MJ, Pilch PF: Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem 273: 7201-7204, 1998
29. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A: Active Rho kinase associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 22: 6214-6222, 2001
30. Waly M, Olteanu H, Banerjee R, Choi S-W, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky V-A, Deth RC: Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopemental toxins and thimerosal. Mol Psychiatry 1-13, 2004
31. Fonesca V, Keebler M, Dicker-Brown A, DeSouza C, Poirier LA, Murthy SN, McNamara DB: The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in zucker rats. Metabolism 61: 783-786, 2002
32. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, Takeshita A: Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 43: 1029-1039, 1999
33. Satoh S, Ikegaki I, Suzuki Y, Asano T, Shibuya M, Hidaka H: Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils. Br J Pharmacol 118: 1592-1596, 1996
34. Kamei S, Oishi M, Takasu T: Evaluation of fasudil hydrochloride treatment for wandering symptoms in cerebrovascular dementia with 31P-magnetic resonance spectroscopy and Xe-computed tomography. Clin Neuropharmacol 19: 428-438, 1996.
35. +2 sensitization of myosin phosphorylation and force in guinea-pig ileum. J Physiol 522: 33-49, 2000
36. Hayden MR, Tyagi SC: Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleotropic effects of folate supplementation. Nutrition J 3: 4-27, 2004